A leading-edge technology now available at Brigham and Women’s Faulkner Hospital (BWFH) offers a new approach to visualizing and treating bladder cancer—and new hope for patients.

BWFH is one of a select few U.S. institutions—and the only Partners hospital—to offer the approach, called Blue Light Cystoscopy with Cysview®. It allows physicians to visualize the bladder’s interior wall using a cystoscope, a thin tube with both white and blue light and a video camera on the end. The use of Cysview® before the procedure makes cancer cells glow bright fluorescent pink in blue light, standing out against the blue of the healthy tissue, for clearer visualization of non-muscle invasive cancer lesions.

“We are always looking for advances in technology and treatment—and studies show that this approach can reduce recurrence rates and hopefully will improve long-term outcomes for patients,” notes Mark Preston, MD, MPH, Brigham Health urological surgeon.

Read more here.

Topics: redesigning care, research and discovery, Technology

View all Topics View Archives